Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Impact investing – time to capture…

Sometimes one bottom line is not enough. Many investors are no longer satisfied simply by turning a profit. More and more also want their investments to generate a positive impact in the world.

New title for a new era…

Global Government Venturing over the past five years has followed the increasing engagement of sovereign wealth funds and states in the innovation capital ecosystem.

Hyperloop One digs into $172m

DP World has returned to lead a $172m funding round for the advanced transport technology developer, having previously co-led a $50m round in 2017.

Rimac rides Hyundai to new funding
Hyundai and subsidiary Kia have provided $93.7m in capital for electric vehicle developer Rimac Automobili through a partnership deal that will involve them collaborating on new models.
Impossible Foods impresses with $300m
Alphabet-backed vegan burger producer Impossible will use the funding, secured at a $2bn valuation, to increase production capacity.
Nabard sows $99m for investment fund
Nabard’s food, agriculture and rural development-focused investment vehicle, Nabventures, has reached its first close and has a ceiling of nearly $100m.
LetsGetChecked sets down $30m series B
The Optum-backed round was led by Leerink Transformation Partners and will fund the home medical test provider's international expansion plans.
Verve Therapeutics pumps in series A funding
GV led a $58.5m round for the heart disease drug developer, which came in the wake of a partnership with another Alphabet subsidiary, Verily.
Twentyeight-Seven recalculates series A round
Johnson & Johnson, Novartis and Astellas all took part in the first close of a round for oncology therapy developer 28-7 Therapeutics that now stands at $82.8m.
test reg